Caira Surgical secures $ 5 million for robotic solutions for joint replacement surgery

Caira Surgical secures $ 5 million for robotic solutions for joint replacement surgery

What you should know:

– Caira Surgical, a revolutionary computer-assisted navigation system for leadership replacement surgery, raises $ 5 million from serial seed investors to include a leading OUS Strategic and several MedTech venture funds. These include US-based Mountain State Capital; Amsterdam-based Snowboat BV, a Dutch foundation formed by the founders of Avania Clinical (formerly Factory-CRO); and Grenoble, France-based Haventure, founded by Stephane Lavallee, Ph.D. Dr. Lavallee is also the founder of the surgical robotics company eCentenial.

– Caira is developing its groundbreaking innovations as a platform technology that will expand to address hip and shoulder prosthesis surgery and spinal applications.


Conceived by surgeons dissatisfied with complacent innovation

Caira Surgical secures $ 5 million for robotic solutions for joint replacement surgery

Caira was founded in 2019 and challenges and makes progress far beyond the conventional norms of surgical procedures. Caira’s proprietary technology seeks to revolutionize the usability, safety and availability of advanced surgical navigation and robotic technology for orthopedic surgery. The company’s first product is a groundbreaking sub-millimeter-accurate radar tracking system for knee replacement surgery. The system utilizes advanced radar technologies to overcome line-of-sight interference and eliminate invasive surgical hardware and high-cost, large footprint capital equipment inherent with existing surgical tracking systems.

“We are excited to reach this financing milestone in partnership with our industry-savvy investors,” said Jon Greenwald, co-founder and CEO of Caira Surgical. The strategic Medtech leader for more than 20 years explained, “the start-up financing of the series enables Caira to continue to develop our cutting-edge technology and have a positive impact on orthopedic surgery and patient welfare. In addition, the composition, commitment and enthusiasm of our investor syndicate Caira will continue to have access to the funding and resources needed to realize our technology vision and meet our commercial goals. “

Give a Comment